Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications
暂无分享,去创建一个
[1] B. S. Mohammed,et al. Relationship Between Body Fat Mass and Free Fatty Acid Kinetics in Men and Women , 2009, Obesity.
[2] B. Fielding,et al. Liver fat and lipid oxidation in humans , 2009, Liver international (Print).
[3] B. S. Mohammed,et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.
[4] A. Lecube,et al. Increased Expression and Activity of Hepatic Lipase in the Liver of Morbidly Obese Adult Patients in Relation to Lipid Content , 2009, Obesity surgery.
[5] D. Reeds,et al. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. , 2009, Gastroenterology.
[6] T. Okanoue,et al. Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[7] B. S. Mohammed,et al. Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss , 2009, Diabetes.
[8] M. Watt. STORING UP TROUBLE: DOES ACCUMULATION OF INTRAMYOCELLULAR TRIGLYCERIDE PROTECT SKELETAL MUSCLE FROM INSULIN RESISTANCE? , 2009, Clinical and experimental pharmacology & physiology.
[9] G. Musso,et al. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). , 2009, Progress in lipid research.
[10] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[11] J. Olefsky,et al. Insulin sensitivity: modulation by nutrients and inflammation. , 2008, The Journal of clinical investigation.
[12] K. Reynolds,et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.
[13] J. Rood,et al. Effect of 6‐Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver Function , 2008, Obesity.
[14] J. Helge,et al. Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity , 2008, Diabetologia.
[15] B. S. Mohammed,et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.
[16] R. O’Doherty,et al. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. , 2008, American journal of physiology. Endocrinology and metabolism.
[17] D. Greco,et al. Gene expression in human NAFLD. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[18] P. Lundberg,et al. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects , 2008, Gut.
[19] Ramesh Natarajan,et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. , 2008, Gastroenterology.
[20] B. S. Mohammed,et al. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. , 2008, Gastroenterology.
[21] R. Dalle Grave,et al. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach , 2007, Hepatology.
[22] J. H. Kim,et al. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty‐acid metabolic enzymes , 2006, Journal of gastroenterology and hepatology.
[23] N. Barzilai,et al. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. , 2007, American journal of physiology. Endocrinology and metabolism.
[24] Robert V Farese,et al. Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. , 2007, American journal of physiology. Endocrinology and metabolism.
[25] A. Hamsten,et al. Genes Involved in Fatty Acid Partitioning and Binding, Lipolysis, Monocyte/Macrophage Recruitment, and Inflammation Are Overexpressed in the Human Fatty Liver of Insulin-Resistant Subjects , 2007, Diabetes.
[26] G. Shulman,et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.
[27] S. Grundy,et al. Metabolic correlates of nonalcoholic fatty liver in women and men , 2007, Hepatology.
[28] K. Kotoh,et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. , 2007, International journal of molecular medicine.
[29] A. Häkkinen,et al. Adipose Tissue Inflammation and Increased Ceramide Content Characterize Subjects With High Liver Fat Content Independent of Obesity , 2007, Diabetes.
[30] X. Papademetris,et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.
[31] Robert V Farese,et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. , 2007, Cell metabolism.
[32] S. McCall,et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis , 2007, Hepatology.
[33] Shuli Wang,et al. Hepatic Overexpression of Glycerol-sn-3-phosphate Acyltransferase 1 in Rats Causes Insulin Resistance* , 2007, Journal of Biological Chemistry.
[34] Laura Herrero,et al. Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.
[35] Richard E Gregg,et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. , 2007, The New England journal of medicine.
[36] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[37] Claudio Cobelli,et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men , 2006, Proceedings of the National Academy of Sciences.
[38] D. Brenner,et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. , 2006, Gastroenterology.
[39] G. Shulman,et al. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.
[40] M. Pagliassotti,et al. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.
[41] A. Häkkinen,et al. Overproduction of large VLDL particles is driven by increased liver fat content in man , 2006, Diabetologia.
[42] G. Pacini,et al. Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease , 2005, Hepatology.
[43] J. Romijn,et al. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[44] B. Monia,et al. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice , 2005, Hepatology.
[45] T. Magnuson,et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. , 2005, Obesity research.
[46] S. Sanderson,et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.
[47] G. Marchesini,et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. , 2005, The Journal of clinical endocrinology and metabolism.
[48] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[49] J. Jessurun,et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.
[50] J. Cline,et al. Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. , 2005, Gastroenterology.
[51] J. Schneider,et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.
[52] D. Cook,et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. , 2005, American journal of physiology. Endocrinology and metabolism.
[53] E. Ferrannini,et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.
[54] S. Grundy,et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.
[55] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.
[56] R. Kaufman,et al. The mammalian unfolded protein response. , 2003, Annual review of biochemistry.
[57] H. Greene,et al. Fatty liver: Biochemical and clinical considerations , 1975, The American Journal of Digestive Diseases.
[58] S. Shoelson,et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.
[59] S. Klein,et al. THE MALNOURISHED PATIENT : NUTRITIONAL ASSESSMENT AND MANAGEMENT , 2005 .
[60] Jonathan C. Cohen,et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.
[61] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[62] D. Befroy,et al. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.
[63] J. Dixon,et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss , 2004, Hepatology.
[64] Donald D Hensrud,et al. Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.
[65] K. Iizuka,et al. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[66] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[67] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[68] M. Beylot,et al. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.
[69] J. Arenas,et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.
[70] Yu Wang,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.
[71] G. Marchesini,et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.
[72] N. Chalasani,et al. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis , 2003, Hepatology.
[73] D. Yablonskiy,et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. , 2003, Journal of lipid research.
[74] S. Klein,et al. Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. , 2003, American journal of physiology. Endocrinology and metabolism.
[75] J. Everhart,et al. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.
[76] A. Häkkinen,et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.
[77] M. Monden,et al. Hepatic Blood Flow Measurements With Arterial and Portal Blood Flow Mapping in the Human Liver by Means of Xenon CT , 2002, Journal of computer assisted tomography.
[78] D. Kotler,et al. Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery , 2002, Obesity surgery.
[79] N. Barzilai,et al. Overfeeding rapidly induces leptin and insulin resistance. , 2001, Diabetes.
[80] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[81] M. Sakurai,et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[83] E. A. Sims,et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? , 2001, The Journal of clinical endocrinology and metabolism.
[84] R. Fisher,et al. Selection and outcome of living donors for adult to adult right lobe transplantation. , 2000, Transplantation.
[85] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[86] I. Shimomura,et al. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[87] H. Cortez‐Pinto,et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.
[88] Jay D. Horton,et al. Increased Levels of Nuclear SREBP-1c Associated with Fatty Livers in Two Mouse Models of Diabetes Mellitus* , 1999, The Journal of Biological Chemistry.
[89] W. Wahli,et al. Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.
[90] J. Parks,et al. Mitochondrial abnormalities in non-alcoholic steatohepatitis. , 1999, Journal of hepatology.
[91] M. Brown,et al. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. , 1999, The Journal of clinical investigation.
[92] A. Scheen,et al. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty , 1998, International Journal of Obesity.
[93] E. Ferrannini,et al. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). , 1997, The Journal of clinical investigation.
[94] G. Lewis. Fatty acid regulation of very low density lipoprotein production. , 1997, Current opinion in lipidology.
[95] R. Hammer,et al. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. , 1997, The Journal of clinical investigation.
[96] M. Müller. Hepatic fuel selection , 1995, Proceedings of the Nutrition Society.
[97] Randall G. Lee,et al. Nonalcoholic steatohepatitis: a study of 49 patients. , 1989, Human pathology.
[98] J. McGarry,et al. Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.
[99] P. Christoffersen,et al. Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties. , 1977, Scandinavian journal of gastroenterology.